Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

FDA Approval: Ibrutinib for Patients with Previously Treated Mantle Cell Lymphoma and Previously Treated Chronic Lymphocytic Leukemia.

de Claro RA, McGinn KM, Verdun N, Lee SL, Chiu HJ, Saber H, Brower ME, Chang CJ, Pfuma E, Habtemariam B, Bullock J, Wang Y, Nie L, Chen XH, Lu DR, Al-Hakim A, Kane RC, Kaminskas E, Justice R, Farrell AT, Pazdur R.

Clin Cancer Res. 2015 Aug 15;21(16):3586-90. doi: 10.1158/1078-0432.CCR-14-2225.

2.

An experimental evaluation of patient decision aid design to communicate the effects of medications on the rate of progression of structural joint damage in rheumatoid arthritis.

Martin RW, Brower ME, Geralds A, Gallagher PJ, Tellinghuisen DJ.

Patient Educ Couns. 2012 Mar;86(3):329-34. doi: 10.1016/j.pec.2011.06.001. Epub 2011 Jul 12.

PMID:
21752570
3.

Approval summary for bortezomib for injection in the treatment of multiple myeloma.

Bross PF, Kane R, Farrell AT, Abraham S, Benson K, Brower ME, Bradley S, Gobburu JV, Goheer A, Lee SL, Leighton J, Liang CY, Lostritto RT, McGuinn WD, Morse DE, Rahman A, Rosario LA, Verbois SL, Williams G, Wang YC, Pazdur R.

Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):3954-64. No abstract available.

4.

Regulatory considerations for preclinical development of anticancer drugs.

DeGeorge JJ, Ahn CH, Andrews PA, Brower ME, Giorgio DW, Goheer MA, Lee-Ham DY, McGuinn WD, Schmidt W, Sun CJ, Tripathi SC.

Cancer Chemother Pharmacol. 1998;41(3):173-85. Review.

PMID:
9443633
5.

Considerations for toxicology studies of respiratory drug products.

DeGeorge JJ, Ahn CH, Andrews PA, Brower ME, Choi YS, Chun MY, Du T, Lee-Ham DY, McGuinn WD, Pei L, Sancilio LF, Schmidt W, Sheevers HV, Sun CJ, Tripathi S, Vogel WM, Whitehurst V, Williams S, Taylor AS.

Regul Toxicol Pharmacol. 1997 Apr;25(2):189-93. Review.

PMID:
9185894
6.

Growth-rate periodicity of Streptomyces levoris during space flight.

Rogers TD, Brower ME, Taylor GR.

Life Sci Space Res. 1977;15:299-305.

PMID:
11962504
7.

Sodium thymolphthalein monophosphate: a new acid phosphatase substrate with greater specificity for the prostatic enzyme in serum.

Roy AV, Brower ME, Hayden JE.

Clin Chem. 1971 Nov;17(11):1093-102. No abstract available.

PMID:
5127366

Supplemental Content

Loading ...
Support Center